232 related articles for article (PubMed ID: 30955150)
1. Synthesis, anti-proliferative activity, theoretical and
Brito VBM; Santos GF; Silva TDS; Souza JLC; Militão GCG; Martins FT; Silva FPL; Oliveira BG; Araújo ECC; Vasconcellos MLAA; Lima-Júnior CG; Alencar-Filho EB
Mol Divers; 2020 Feb; 24(1):265-281. PubMed ID: 30955150
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts.
Lima- CG; Faheina-Martins GV; Bomfim CC; Dantas BB; Silva EP; Araújo DA; Filho EB; Vasconcellos ML
Med Chem; 2016; 12(7):602-612. PubMed ID: 27150963
[TBL] [Abstract][Full Text] [Related]
3. Highly enantioselective [3 + 2]-annulation of isatin-derived morita-baylis-hillman adducts with cyclic sulfonimines.
Wei F; Huang HY; Zhong NJ; Gu CL; Wang D; Liu L
Org Lett; 2015 Apr; 17(7):1688-91. PubMed ID: 25781216
[TBL] [Abstract][Full Text] [Related]
4. (DHQ)2AQN-catalyzed asymmetric substitution of isatin-derived hydrazones with O-Boc-protected Morita-Baylis-Hillman adducts: A strategy for synthesizing enantioenriched azo compounds incorporating an oxindole scaffold.
Yang HB; Zhao YZ; Sang R; Shi M
J Org Chem; 2014 Apr; 79(8):3519-28. PubMed ID: 24670223
[TBL] [Abstract][Full Text] [Related]
5. QSAR study of isatin analogues as in vitro anti-cancer agents.
Sabet R; Mohammadpour M; Sadeghi A; Fassihi A
Eur J Med Chem; 2010 Mar; 45(3):1113-8. PubMed ID: 20056518
[TBL] [Abstract][Full Text] [Related]
6. Pyridine core activation via 1,5-electrocyclization of vinyl pyridinium ylides generated from bromo isomerized Morita-Baylis-Hillman adduct of isatin and pyridine: synthesis of 3-spirodihydroindolizine oxindoles.
Viswambharan B; Selvakumar K; Madhavan S; Shanmugam P
Org Lett; 2010 May; 12(9):2108-11. PubMed ID: 20373746
[TBL] [Abstract][Full Text] [Related]
7. Isatin derivatives with activity against apoptosis-resistant cancer cells.
Evdokimov NM; Magedov IV; McBrayer D; Kornienko A
Bioorg Med Chem Lett; 2016 Mar; 26(6):1558-1560. PubMed ID: 26883150
[TBL] [Abstract][Full Text] [Related]
8. Transformations of Modified Morita-Baylis-Hillman Adducts from Isatins Catalyzed by Lewis Bases.
Chen ZC; Chen Z; Du W; Chen YC
Chem Rec; 2020 Jun; 20(6):541-555. PubMed ID: 31609533
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
[TBL] [Abstract][Full Text] [Related]
10. [4 + 3] Cycloadditions with Bromo-Substituted Morita-Baylis-Hillman Adducts of Isatins and N-(ortho-Chloromethyl)aryl Amides.
Zhan G; Shi ML; He Q; Du W; Chen YC
Org Lett; 2015 Oct; 17(19):4750-3. PubMed ID: 26359687
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds.
Wang J; Yun D; Yao J; Fu W; Huang F; Chen L; Wei T; Yu C; Xu H; Zhou X; Huang Y; Wu J; Qiu P; Li W
Eur J Med Chem; 2018 Jan; 144():493-503. PubMed ID: 29288946
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric allylic alkylation of isatin-derived Morita-Baylis-Hillman carbonates with nitroalkanes.
Chen GY; Zhong F; Lu Y
Org Lett; 2012 Aug; 14(15):3955-7. PubMed ID: 22830594
[TBL] [Abstract][Full Text] [Related]
14. An enantioselective organocatalyzed aza-Morita-Baylis-Hillman reaction of isatin-derived ketimines with acrolein.
Yoshida Y; Sako M; Kishi K; Sasai H; Hatakeyama S; Takizawa S
Org Biomol Chem; 2015 Sep; 13(34):9022-8. PubMed ID: 26214279
[TBL] [Abstract][Full Text] [Related]
15. Tertiary amine-catalyzed chemoselective and asymmetric [3 + 2] annulation of Morita-Baylis-Hillman carbonates of isatins with propargyl sulfones.
Peng J; Huang X; Jiang L; Cui HL; Chen YC
Org Lett; 2011 Sep; 13(17):4584-7. PubMed ID: 21815615
[TBL] [Abstract][Full Text] [Related]
16. Combined 4D-QSAR and target-based approaches for the determination of bioactive Isatin derivatives.
Sahin K; Saripinar E; Durdagi S
SAR QSAR Environ Res; 2021 Oct; 32(10):769-792. PubMed ID: 34530651
[TBL] [Abstract][Full Text] [Related]
17. Morita-Baylis-Hillman adducts and their derivatives: a patent-based exploration of diverse biological activities.
Porto RS; Porto VA
Pharm Pat Anal; 2023 May; 12(3):127-141. PubMed ID: 37671921
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective Morita-Baylis-Hillman reaction of isatins with acrylates: facile creation of 3-hydroxy-2-oxindoles.
Zhong F; Chen GY; Lu Y
Org Lett; 2011 Jan; 13(1):82-5. PubMed ID: 21138329
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives.
Nagarsenkar A; Guntuku L; Guggilapu SD; K DB; Gannoju S; Naidu VGM; Bathini NB
Eur J Med Chem; 2016 Nov; 124():782-793. PubMed ID: 27639369
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity.
Pakravan P; Kashanian S; Khodaei MM; Harding FJ
Pharmacol Rep; 2013; 65(2):313-35. PubMed ID: 23744416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
